secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0001193125-24-148151
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma shareholders approve equity plan amendment to 5% annual share increase, elect directors
--------------------------------------------------------------------------------

- Shareholders approved amended 2021 Equity Incentive Plan raising automatic annual share increase from 4% to 5% through 2034.
- Robert Ang and Sven (Bill) Ante Lundberg were elected as Class III directors until the 2027 annual meeting.
- Ernst & Young ratified as independent auditor for fiscal year 2024.
- Plan amendment received 36.8M votes for, 20.9M against; 4.4M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524148151/0001193125-24-148151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524148151/d829841d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-148151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer